Contact info@epaad.org for more information
  • Home
  • Knowledge
    • Introduction
    • Publications
  • Data
    • Gene Expresssion Database
    • Metabolomics Database
  • Resources
    • Antibodies
    • Animal Models
  • APOE U19
  • About us
  • Home
  • Knowledge
    • Introduction
    • Publications
  • Data
    • Gene Expresssion Database
    • Metabolomics Database
  • Resources
    • Antibodies
    • Animal Models
  • APOE U19
  • About us

ApoE and TDP-43

Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43. Wennberg, A. M., Tosakulwong, N., Lesnick, T. G., Murray, M. E., Whitwell, J. L., Liesinger, A. M., Petrucelli, L., Boeve, B. F., Parisi, J. E., Knopman, D. S., Petersen, R. C., Dickson, D. W., & Josephs, K. A. (2018).  JAMA neurology, 75(11), 13471354.

Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study. Yang, H. S., Yu, L., White, C. C., Chibnik, L. B., Chhatwal, J. P., Sperling, R. A., Bennett, D. A., Schneider, J. A., & De Jager, P. L. (2018).  The Lancet. Neurology, 17(9), 773781.

Fitting TDP-43 into the APOE ε4 and neurodegeneration story. Josephs K. A. (2018).  The Lancet. Neurology, 17(9), 735737.

Join Our Newsletter

Success!

SIGN UP

info@epaad.org

Copyright © 2023 EPAAD

Site by Jax Media Team